| Product Code: ETC8558680 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Dry Age Macular Degeneration Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Dry Age Macular Degeneration Market - Industry Life Cycle |
3.4 New Zealand Dry Age Macular Degeneration Market - Porter's Five Forces |
3.5 New Zealand Dry Age Macular Degeneration Market Revenues & Volume Share, By Stages, 2021 & 2031F |
3.6 New Zealand Dry Age Macular Degeneration Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.7 New Zealand Dry Age Macular Degeneration Market Revenues & Volume Share, By Diagnosis and Treatment, 2021 & 2031F |
3.8 New Zealand Dry Age Macular Degeneration Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 New Zealand Dry Age Macular Degeneration Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 New Zealand Dry Age Macular Degeneration Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration in New Zealand's aging population |
4.2.2 Advances in diagnostic technologies leading to early detection and treatment |
4.2.3 Growing awareness about the importance of eye health and regular screenings |
4.3 Market Restraints |
4.3.1 Limited access to specialized eye care services in remote areas of New Zealand |
4.3.2 High costs associated with advanced treatments and medications |
4.3.3 Regulatory challenges and delays in the approval of new therapies |
5 New Zealand Dry Age Macular Degeneration Market Trends |
6 New Zealand Dry Age Macular Degeneration Market, By Types |
6.1 New Zealand Dry Age Macular Degeneration Market, By Stages |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Stages, 2021- 2031F |
6.1.3 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Early Age-Related Macular Degeneration, 2021- 2031F |
6.1.4 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Intermediate Age-Related Macular Degeneration, 2021- 2031F |
6.1.5 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Late Age-Related Macular Degeneration, 2021- 2031F |
6.2 New Zealand Dry Age Macular Degeneration Market, By Age Group |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Above 75 Years, 2021- 2031F |
6.2.3 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Above 60 Years, 2021- 2031F |
6.2.4 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Above 40 Years, 2021- 2031F |
6.3 New Zealand Dry Age Macular Degeneration Market, By Diagnosis and Treatment |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Treatment, 2021- 2031F |
6.3.3 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.4 New Zealand Dry Age Macular Degeneration Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Injectables, 2021- 2031F |
6.5 New Zealand Dry Age Macular Degeneration Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.3 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.5.4 New Zealand Dry Age Macular Degeneration Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
7 New Zealand Dry Age Macular Degeneration Market Import-Export Trade Statistics |
7.1 New Zealand Dry Age Macular Degeneration Market Export to Major Countries |
7.2 New Zealand Dry Age Macular Degeneration Market Imports from Major Countries |
8 New Zealand Dry Age Macular Degeneration Market Key Performance Indicators |
8.1 Average age at diagnosis of dry age-related macular degeneration in New Zealand |
8.2 Number of ophthalmologists specializing in macular degeneration per capita |
8.3 Percentage of the population receiving regular eye screenings for early detection of macular degeneration |
9 New Zealand Dry Age Macular Degeneration Market - Opportunity Assessment |
9.1 New Zealand Dry Age Macular Degeneration Market Opportunity Assessment, By Stages, 2021 & 2031F |
9.2 New Zealand Dry Age Macular Degeneration Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.3 New Zealand Dry Age Macular Degeneration Market Opportunity Assessment, By Diagnosis and Treatment, 2021 & 2031F |
9.4 New Zealand Dry Age Macular Degeneration Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 New Zealand Dry Age Macular Degeneration Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 New Zealand Dry Age Macular Degeneration Market - Competitive Landscape |
10.1 New Zealand Dry Age Macular Degeneration Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Dry Age Macular Degeneration Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |